SG/PUT/NOVO-NORDISK B/750/0.1/20.09.24 | Delayed Deutsche Boerse AG 08:11:10 01/07/2024 pm IST | ||
| 0.067 EUR | -2.90% |
|
| Current month | -56.88% | ||
| 1 month | -59.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
| Date | Price | Change |
|---|---|---|
| 01/24/01 | 0.067 | -2.90% |
| 28/24/28 | 0.069 | -4.17% |
| 27/24/27 | 0.072 | +2.86% |
| 26/24/26 | 0.07 | +29.63% |
| 25/24/25 | 0.054 | -27.03% |
Delayed Quote Deutsche Boerse AG
Last update July 01, 2024 at 08:11 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Société Générale
|
| WKN | SU0M7Y |
| ISIN | DE000SU0M7Y5 |
| Date issued | 12/10/2023 |
| Strike | 750 kr |
| Maturity | 20/09/2024 (81 Days) |
| Parity | 10 : 1 |
| Emission price | 1.65 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.83 € |
|---|---|
| Lowest since issue | 0.046 € |
| Delta | 0x |
| Omega | 0.000000 |
| Premium | 0x |
| Gearing | 183.8x |
| Moneyness | 0.7488 |
| Difference Strike | -254.6 kr |
| Difference Strike % | -33.95% |
| Spread | 0.01 € |
| Spread % | 12.82% |
| Intrinsic value | 0.000000 |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006
DKK
Average target price
949.7
DKK
Spread / Average Target
-5.56%
- Stock Market
- Warrants
- Warrant
